Titan Pharma: Titan Pharma stock trading halted ahead of FDA meeting
The Advisory Committee of the U.S. FDA to discuss the new drug application for the company's lead product candidate Probuphine
Read full article »
Titan Pharma manufactures and markets pharmaceutical raw materials, drug intermediates, and finished formulations.
Read more